Message from the President
I hope that this letter finds you healthy and safe. ISPD had a busy few months with our first-ever virtual conference, which was held in early June attracting 533 attendees from 43 countries. The five countries with the greatest attendance were the U.S., Canada, Singapore, the Netherlands, and Australia. As you can see, this was a truly global meeting, and we thank all who participated to make it a successful event. We felt that running it in two time zones made it a truly global conference, allowing many to attend who might have not been able to otherwise.
We look forward to building on the success of the conference with the continuation of the Virtual Education Series of “What to tell the patients” webinars starting back up again in September. There are also plans for a Genomics Bootcamp for Healthcare Practitioners, and of course, our next conference will take place in June 2022 in Montréal. We are currently planning to hold a hybrid conference in 2022 with options for in-person and virtual participation to ensure that anyone who cannot travel for whatever reason can have the opportunity to join the meeting. Stay tuned for more details on all these programs.
I want to thank everyone who has contributed articles, reviews, and/or their editorial or reviewing skills to our official journal, Prenatal Diagnosis. The journal’s impact factor (IF) increased by 25% this year to 3.05. Reviews contributed significantly to the increase in IF and if you have ideas for a review that you think would be particularly useful to our members and readers, please do get in touch as these are likely to be highly cited. Finally, if you have work you want to publish that concerns prenatal genetics or fetal therapy – with the increase in IF, Prenatal Diagnosis may be the journal of choice!
For those of you in sunny climates – enjoy the rest of the summer, and all stay safe in these troubled times.
Lyn Chitty, PhD, MRCOG